Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Karyopharm Therapeutics (KPTI)
NASDAQ:KPTI
RESEARCH TOOLSreports
Karyopharm Therapeutics (KPTI) Ownership - Who Owns Karyopharm Therapeutics?
937 Followers
Karyopharm Therapeutics (KPTI) Ownership Overview
The ownership structure of Karyopharm Therapeutics (KPTI) stock is a mix of institutional, retail and individual investors. Approximately 52.88% of the company’s stock is owned by Institutional Investors, 8.33% is owned by Insiders and 38.79% is owned by Public Companies and Individual Investors.
8.33% Insiders
13.51% Mutual Funds
39.37% Other Institutional Investors
38.79% Public Companies and
Individual Investors
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 12, 2023 | Garen Bohlin Director | Bought | $49779 |
| Mar 07, 2023 | Paulson Richard A. President & Ceo,director | Sold | $11079 |
| Mar 02, 2023 | Paulson Richard A. President & Ceo,director | Sold | $99760 |
| Mar 02, 2023 | Michael Mason Evp, Cfo & Treas | Sold | $33839 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2023 | Bought | $110294 | |
| Sep 30, 2023 | Bought | $179710 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,000,000.00 | Insider | 5.24% | 5,100,000.00 | |
| 5,448,188.00 | Institution | 4.76% | 4,630,959.80 | |
| 5,159,612.00 | Institution | 4.50% | 4,385,670.20 | |
| 4,919,757.00 | Institution | 4.30% | 4,181,793.45 | |
| 3,861,366.00 | Institution | 3.37% | 3,282,161.10 | |
| 2,262,243.00 | Institution | 1.98% | 1,922,906.55 | |
| 1,926,782.00 | Institution | 1.68% | 1,637,764.70 | |
| 1,671,888.00 | Insider | 1.46% | 1,421,104.80 | |
| 1,611,888.00 | Insider | 1.41% | 1,370,104.80 | |
| 1,564,670.00 | Institution | 1.37% | 1,329,969.50 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,919,757.00 | Institution | 4.30% | 4,181,793.45 | |
| 2,262,243.00 | Institution | 1.98% | 1,922,906.55 | |
| 1,564,670.00 | Institution | 1.37% | 1,329,969.50 | |
| 1,125,000.00 | Institution | 0.98% | 956,250.00 | |
| 1,054,789.00 | Institution | 0.92% | 896,570.65 | |
| 971,615.00 | Institution | 0.85% | 825,872.75 | |
| 891,268.00 | Institution | 0.78% | 757,577.80 | |
| 426,788.00 | Institution | 0.37% | 362,769.80 | |
| 380,000.00 | Institution | 0.33% | 323,000.00 | |
| 304,343.00 | Institution | 0.27% | 258,691.55 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,209,249.00 | Institution | 2.80% | 2,792,047.00 | |
| 2,686,307.00 | Institution | 2.35% | 2,285,778.63 | |
| 1,514,162.00 | Institution | 1.32% | 1,317,321.00 | |
| 974,516.00 | Institution | 0.85% | 829,215.66 | |
| 703,891.00 | Institution | 0.61% | 598,940.85 | |
| 712,696.00 | Institution | 0.62% | 579,849.47 | |
| 712,696.00 | Institution | 0.62% | 579,849.47 | |
| 712,696.00 | Institution | 0.62% | 579,849.47 | |
| 556,081.00 | Institution | 0.49% | 452,427.50 | |
| 556,081.00 | Institution | 0.49% | 452,427.50 |
FAQ
Who Owns Karyopharm Therapeutics (KPTI)?
According to the latest TipRanks data, approximately 39.37% of the company's stock is held by institutional investors, 8.33% is held by insiders, and 38.79% is held by retail investors.
What percentage of Karyopharm Therapeutics (KPTI) stock is held by institutional investors?
According to the latest TipRanks data, approximately 39.37% of Karyopharm Therapeutics (KPTI) stock is held by institutional investors.
What percentage of Karyopharm Therapeutics (KPTI) stock is held by retail investors?
According to the latest TipRanks data, approximately 38.79% of Karyopharm Therapeutics (KPTI) stock is held by retail investors.
Who owns the most shares of Karyopharm Therapeutics (KPTI)?
Chione Ltd owns the most shares of Karyopharm Therapeutics (KPTI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.